US20010025198A1 - UV blocking lenses and material containing benzotriazoles and benzophenones - Google Patents

UV blocking lenses and material containing benzotriazoles and benzophenones Download PDF

Info

Publication number
US20010025198A1
US20010025198A1 US09/838,992 US83899201A US2001025198A1 US 20010025198 A1 US20010025198 A1 US 20010025198A1 US 83899201 A US83899201 A US 83899201A US 2001025198 A1 US2001025198 A1 US 2001025198A1
Authority
US
United States
Prior art keywords
lens
och
absorber
aryl
benzophenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/838,992
Inventor
Hermann Faubl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Wesley Jessen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wesley Jessen Inc filed Critical Wesley Jessen Inc
Priority to US09/838,992 priority Critical patent/US20010025198A1/en
Publication of US20010025198A1 publication Critical patent/US20010025198A1/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WESLEY JESSEN CORPORATION
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses

Definitions

  • This invention relates to transparent plastic materials for optical use, and particularly to ocular devices which absorb ultraviolet radiation, and to their production from ultraviolet absorbing compounds, such as by copolymerizing the compounds with suitable reactive monomers.
  • UV ultraviolet
  • Such lenses are useful to all who live in areas where bright sunlight is common.
  • UV radiation is likely to be a cause of cataracts and senile macular degeneration, everyone who wears contact lenses can benefit from the type which block this radiation.
  • UV absorbing intraocular lenses are also highly desirable, since such lenses are implanted in place of the eye's natural lens.
  • Hydrogels are desirable for use in lenses, particularly IOLs.
  • Prior art UV absorbers are generally hydrophobic and have limited solubility in hydrogels. Due in part to this limited solubility, it has been difficult to copolymerize UV absorbers with hydrogel forming monomers. UV absorbers are preferably copolymerized, rather than physically entrapped within the hydrogel, to prevent the absorber from being leached out of the UV absorbing hydrogel when the hydrogel is in the aqueous environment of the eye or stored in solution.
  • UV absorbers having the required characteristics such as UV absorption between 300-400 nm and hydrolytic stability have been difficult to synthesize.
  • UVA UV Absorption
  • UVB range UVB range
  • UVA range UVA range
  • Hung et al. U.S. Pat. No. 4,963,160, proposes a solution to some of these problems by bonding two different UV absorbing compounds that each have a different UV absorbing spectra onto a triazine derivative, which is then applied as a coating onto a polymeric lens.
  • the UV absorbers are preferably selected to provide a UV absorbing agent with the broadest UV absorption range possible.
  • Hung et al. disclosed embodiments of these UV absorbing agents that include p-aminobenzoic acid and a benzotriazole, or p-aminobenzoic acid and a benzophenone.
  • the use of this UV absorbing agent has certain limitations because the UV absorbing compounds can only be used in a one-to-one mole ratio, so that the UV absorption spectra of the lens cannot be optimized Also, there are difficulties to achieve consistent coating thicknesses.
  • the present invention overcomes some of these problems unsolved by prior art UV blocking lenses by providing a plastic material, preferably in the form a of an ocular device such as a contact lens or an intraocular lens, comprising a polymer formed by incorporating one or more monomers suitable for use in making such lenses, and effective amounts of a combination of a first ultraviolet absorber and a second ultraviolet absorber, wherein the first UV absorber is a benzotriazole compound represented by the formula:
  • R 1a , R 1b , and R 1c are independently hydrogen, halogen, C 1 -C 6 straight or branched chain alkoxy group, aryl or substituted aryl;
  • R 2 is hydrogen, lower alkyl, preferably tert-butyl, aryl or substituted aryl;
  • R 3 is hydrogen, lower alkyl, aryl, substituted aryl, or R 4 -R 5 -R 6 , where R 4 is an oxygen or is absent,
  • R 5 is a linking group selected from —(CH 2 ) n O—, —CH(CH 3 )CH 2 O—, —CH 2 CH(CH 3 )O—, —(CH 2 ) n OCH 2 —, —CH(CH 3 )CH 2 OCH 2 —, or —CH 2 CH(CH 3 )OCH 2 — group, or is absent;
  • R 6 is acrylate, methacrylate, styrene or vinyl; and n
  • the second UV absorber is a substituted 2-hydroxy-benzophenone according to the formula:
  • R 7a , R 7b , and R 7c are independently hydrogen, halogen, C 1 -C 6 straight or branched chain alkoxy group, aryl or substituted aryl;
  • R 8 is a linking group selected from alkyl, —(CH 2 ) m O—, —CH(CH 3 )CH 2 O—, —CH 2 CH(CH 3 )O—, —(CH 2 ) m OCH 2 —, —CH(CH 3 )CH 2 OCH 2 —, or —CH 2 CH(CH 3 )OCH 2 — group, or is absent;
  • R 9 is alky, acrylate, methacrylate, styrene or vinyl; and m is 2 or 3.
  • FIG. 1 shows the UV transmission spectra from the formulations of Example 5.
  • percent will be used to represent percentage by weight, unless the context indicates otherwise.
  • Ocular devices contemplated in connection with the present invention include, without limitation, windows, lenses for eyeglasses and instruments such as binoculars, goggles, face shields, contact lenses, intraocular lenses and the like.
  • Contact lenses can include both those for correcting defective visual acuity and the so-called “bandage lenses” which are used in treating eye disorders, as well as the purely cosmetic lenses used for purposes such as changing the apparent eye color.
  • VAZO 64 2,2′-azobis(2-methylpropanenitrile); C 8 H 12 N 4
  • VAZO 52 2,2′-azobis(2,4-dimethylpentanenitrile); C 14 H 24 N 4
  • the present invention includes a contact lens, intraocular lens, or an optical quality plastic comprising a polymer formed by incorporating one or more monomers suitable for use in making such lenses, and effective amounts of a first ultraviolet absorber and a second ultraviolet absorber to provide amounts of UV absorption to meet ANSI Class 1 specifications without creating an observable yellowish tint to the lens, wherein the first UV absorber is a benzotriazole compound represented by the formula:
  • R 1a , R 1b , and R 1c are independently hydrogen, halogen, C 1 -C 6 straight or branched chain alkoxy group, aryl or substituted aryl;
  • R 2 is hydrogen, lower alkyl, preferably tert-butyl, aryl or substituted aryl;
  • R 3 is hydrogen, lower alkyl, aryl, substituted aryl, or R 4 -R 5 -R 6 , where R 4 is an oxygen or is absent,
  • R 5 is a linking group selected from —(CH 2 ) n O—, —CH(CH 3 )CH 2 O—, —CH 2 CH(CH 3 )O—, —(CH 2 ) n OCH 2 —, —CH(CH 3 )CH 2 OCH 2 —, or —CH 2 CH(CH 3 )OCH 2 — group, or is absent;
  • R 6 is acrylate, methacrylate, styrene or vinyl; and n
  • the second UV absorber is a substituted 2-hydroxy-benzophenone according to the formula:
  • R 7a , R 7b , and R 7c are independently hydrogen, halogen, C 1 -C 6 straight or branched chain alkoxy group, aryl or substituted aryl;
  • R 8 is a linking group selected from alkyl, —(CH 2 ) m O—, —CH(CH 3 )CH 2 O—, —CH 2 CH(CH 3 )O—, —(CH 2 ) m OCH 2 —, —CH(CH 3 )CH 2 OCH 2 —, or —CH 2 CH(CH 3 )OCH 2 — group, or is absent;
  • R 9 is alkyl, acrylate, methacrylate, styrene or vinyl; and m is 2 or 3.
  • R 1 are H, Cl and CH 3 O—, more preferably CH 3 O—.
  • R 1a and R 1c are hydrogen when R 1b is methoxy.
  • the preferred substituent group for R 2 is tert-butyl.
  • R 3 is preferably oxygen.
  • R 4 is preferably oxygen.
  • R 5 is preferably selected from —(CH 2 ) 3 OCH 2 — and —(CH 2 ) 2 OCH 2 —, more preferably R 5 is —(CH 2 ) 3 OCH 2 —.
  • R 6 is preferably methacrylate or styrene.
  • the more preferred compound is one wherein R 1 is CH 3 O—; R 2 is —C(CH 3 ) 3 ; R 4 is O; R 5 is —(CH 2 ) 3 OCH 2 —; and R 6 is styrene.
  • the aryl group may optionally be substituted with halogen, alkyl, halogenated alkyl, alkoxy, alkenyl, alkynyl, and amino groups.
  • benzotriazole derivatives that have UV absorbing qualities comparable to those described specifically in this application, may be useful alternatives to those defined by this invention.
  • One skilled in the art may be able to find or synthesize such compounds and apply them in accordance with the teaching of this invention without undue experimentation.
  • a preferred class of benzotriazole compounds are represented by the formula:
  • R 1 and R 5 are as defined above.
  • benzotriazole compounds of this invention are prepared following the procedures described in U.S. Pat. No. 5,637,726, to Collins et al., incorporated herein by reference. For example, reacting a vinylbenzyl chloride with a 2-[2′-hydroxy-5′-(gamma-hydroxyalkoxy)-3′-t-butylphenyl]-5-(alkoxy [or halo])-2H-benzotriazole one obtains the compound of the above formula.
  • the starting benzotriazole can be prepared by the method described in Examples 1-3 of U.S. Pat. No.
  • the first UV absorbing compound may preferably be a benzotriazole derivative represented by the formula:
  • R 1 is a hydrogen, halogen or lower alkoxy
  • R 2 and R 3 are independently hydrogen or lower alkyl.
  • R 1 is halogen, with chlorine being more preferred.
  • R 2 and R 3 are independently hydrogen, methyl or tert-butyl. More preferably, R 2 is tert-butyl.
  • the non-polymerizable benzotriazole derivative of this formula is preferably used for rigid gas permeable contact lenses.
  • a preferred compound is 2-(2′-hydroxy-3′-tert-butyl-5′-methyl-phenyl)-5-chlorobenzotriazole, which is manufactured by Ceiba-Geigy Corp., and commercially available under the trademark TINUVIN-326.
  • the benzophenone compounds preferably R 7 is hydrogen, halogen or alkoxy. More preferably, R 7 is hydrogen or p is zero.
  • R 8 is preferably alkyl, —(CH 2 ) n O—, or absent.
  • R 9 is preferably is alkyl, acrylate, or methacrylate.
  • the second UV absorbers are selected from the group exemplified by 2-hydroxy4-acryloxyethoxy-benzophenone, 2-hydroxy4-methacryloxy-benzophenone, and 2-hydroxy4-methoxy-benzophenone. More preferably, the selected compounds are 2-hydroxy4-acryloxyethoxy-benzophenone or 2-hydroxy4-methacryloxy-benzophenone.
  • 2-hydroxy-4-acryloxyethoxy-benzophenone is selected for use in hydrogel lenses.
  • 2-hydroxy-4-methoxy-benzophenone is selected for use in hydrogel lenses.
  • These compounds are well-known and described, and are either commercially available or easily synthesized.
  • useful amounts of the UV absorbing compounds in a polymer range from about 0.01 percent to about 25 percent, depending upon the intended use for the polymer. In general, it will be desirable to minimize the amount of compound used, so that the physical and chemical properties of the base polymer (other than UV absorption) will not be significantly or detrimentally effected.
  • about 0.05 to about 10 percent of UV absorbers can be used.
  • less than 0.4 percent of the first UV absorbing compound (benzotriazole) may be used.
  • the preferred total amounts of UV absorbers are between about 0.8 and about 3.0 percent, with between about 1.0 and about 2.0 percent being more preferred.
  • the desired ratio of the amount of the first UV absorber to the second UV absorber (e.g. BZT:BP) is between about 5:1 and about 1:3, preferably between about 3:1 and 1:3.
  • the amounts of the individual UV absorbing compounds used depend on the polymer base, thickness of the lens, water or solids content and desired level of UV absorption. The preferred amounts will, of course, vary depending upon the water content and thickness of the lenses. For example, a lens that is twice as thick will need only half the concentration of UV absorber, assuming its water content is the same. On the other hand, a lens twice as thick with doubled water content will require the same concentration of UV absorber.
  • the first and second UV absorbers are present in amounts to provide an enhanced reduction in the level of UV transmission compared to the level of UV transmission than can be achieved by using the same total amount of one UV absorbing compound alone.
  • the two UV absorbing compounds in combination enhance the total effective UV light blockage. Greater blocking of UV light can be achieved using lesser total amounts of the combination of BZT and BP than using a like amount of either BZT or BP alone.
  • the UV absorbing compounds can be copolymerized with a large number of unsaturated and other monomers to produce polymers having enhanced UV blocking properties.
  • Representative useful monomers include, without limitation:
  • olefins either straight- or branched-chain, including ethylene, propene, butenes, pentenes and the like;
  • dienes such as butadiene, and trienes
  • Hydrogels for use in contact lenses or IOLs ideally should contain a UV absorbing compound. This is particularly the case when the lens is to be used to replace the natural lens of the eye lost to injury or disease.
  • the present invention is directed to UV absorbing hydrogels having the following characteristics.
  • the UV absorbing monomer of the UV blocking hydrogel should block UV radiation between about 300-400 nm, because the purpose of incorporating a UV absorber into a hydrogel is to prevent transmittance of UV radiation to the retina. As previously discussed, this function is normally performed by the eye's natural lens, which, however, is damaged by UV radiation.
  • the UV blocking hydrogel should block UV radiation between about 300 to 400 nm, it is desirable that absorbance sharply decrease above 400 nm. If absorbance does not sharply decrease above 400 nm, the UV absorbing hydrogel will take on a significant yellow tint. In some cases, however, some yellow tint may be desired. For example, it has been thought that increased light absorbance in this range by spectacles, goggles, contact lenses, etc., enhances visual acuity.
  • Hydrogels are particularly susceptible to being adversely affected by the addition of other compounds due to their expanded structure.
  • Most UV absorbing monomers with good UV absorbing characteristics are more hydrophobic than hydrogel-forming monomers.
  • the addition of any significant amount of a UV absorbing monomer to a hydrogel forming monomer decreases the water content of the resulting UV absorbing hydrogel. This can adversely impact the desirable properties of the hydrogel. Therefore, it is desirable to use at least two different UV absorbing compounds which in combination have an enhanced effective blocking of UV radiation, thereby minimizing the concentration of absorber required.
  • the UV absorbing hydrogel be stable as a copolymer and in particular exhibit long-term hydrolytic stability. This is a particularly important requirement when the hydrogel is to be used as an IOL and surgically implanted within the eye, since IOLs are generally intended to remain in the eye indefinitely.
  • the UV absorbing compound to be incorporated into the hydrogel must be soluble in the hydrogel-forming monomer so that it can be copolymerized with the hydrogel-forming monomer. It is necessary that the UV absorber be copolymerized with the hydrogel-forming monomer due to the expanded nature of hydrogels. Because of this expanded structure it is impractical to rely on imbedding or dispersing UV-absorbing compounds within the hydrogel as can be done with rigid-gas-permeable (RGP) type lenses. Moreover, copolymerization prevents the UV absorber from being leached from the hydrogel while in the eye or in a storage solution. At a minimum, the UV absorbing monomer should be soluble in the hydrogel forming monomer in an amount sufficient to provide the desired degree of UV absorbance in the UV blocking hydrogel.
  • Ocular devices or UV blocking optical plastics may be produced by incorporating a first UV absorbing compound, a second UV absorbing compound, and at least one monomeric compound suitable for producing an ocular device, preferably in the case of contact and intraocular lenses, hydroxyethyl methacrylate, N-vinyl pyrrplidone, alkyl methacrylates such as methyl methacrylate, aryl methacrylates, silicone methacrylate, glyceryl methacrylate, fluorinated methacrylates, alkyl substituted styrene, or combination thereof.
  • hydroxyethyl methacrylate hydroxyethyl methacrylate
  • N-vinyl pyrrplidone alkyl methacrylates
  • alkyl methacrylates such as methyl methacrylate, aryl methacrylates, silicone methacrylate, glyceryl methacrylate, fluorinated methacrylates, alkyl substituted styrene, or
  • Contact and intraocular lenses in accordance with invention may be hydrophilic, hard, or rigid-gas-permeable (RGP), depending on the monomer or combination thereof in which the UV-absorbing compounds of the invention are incorporated.
  • RGP rigid-gas-permeable
  • the UV absorbers dispersed in the polymer matrix.
  • hydrophilic lenses it is preferred to have the UV absorbers copolymerized with the base lens monomers.
  • Copolymerization may take place by any of the methods well known within the ocular device industry, e.g., by heat or UV light, or with a suitable initiator.
  • Polymerization temperatures are typically 25° to 140° C., more preferably 30° to 100° C., for 5 minutes to 96 hours, more preferably 1 to 24 hours.
  • Suitable polymerization catalysts include azobisisobutyronitrile, available from E. I. DuPont de Nemours Corporation, Wilmington, Del. U.S.A.
  • Vazo 64TM 2,2′-azobis (2,4-dimethylpentanenitrile), available from DuPont as Vazo 52TMm, and 2,5-dimethyl-2,5-bis(2-ethylhexanoylperoxy) hexane, available from Elf-Atochem, Buffalo, N.Y. U.S.A. as Lupersol 256TM, as well as other peroxides.
  • UV light is used to initiate the polymerization, its intensity should be about 0.1 to about 50 milliwatts per square centimeter, more preferably 1 to 5 mW/cm 2 . Generally, the time required is from 1 minute to 10 hours, preferably from 5 minutes to 2 hours. The temperature is between about 20 and 50° C., preferably 25-30° C. Light-created radicals are derived from the initiators such as Vazo 52 and the like.
  • Lenses of the invention may also be produced by first polymerizing a rod of the copolymer, cutting the rod into bonnets or buttons, and machining the bonnets or buttons into lenses, as is well known in the art. If the polymer undergoes a UV cure, the monomer mixture may also be heat cured after exposure to the UV source. Alternatively, the lenses may be produced by any of the known molding or casting techniques, such as the methods referred to by Kindt-Larsen et al. in U.S. Pat. No. 5,039,459. The exact manner used for polymerization and lens shaping is a matter of choice and is not critical to this invention.
  • the hydrated lens had a water content of 53% with a center thickness of 0.083 mm.
  • the hydrated lens had a water content of 74%
  • the hydrated lens had a water content of 38%
  • HEMA-Based Lenses % Weight Ingredient 5a 5b 5c 5d 5e 5f 5g 5h HEMA 52.912 (SAME) EOEMA 05.727 IPA 37.00 EDMA 01.618 MAA 1.057 Vazo-52 0.336 Lupersol 256 0.331 BZT 1.0 0.75 0.5 0.5 0.5 0.75 0.75 1.0 BP* 0.5 0.5 0.5 0.5 — 0.75 0.75 — Methyl- — — — 0.5 0.5 — 0.75 1.0 BZT** % H 2 O 49 51 50 49 50 48 47 48 Avg. % T 0.45 0.92 2.26 0.25 1.23 0.34 0.25 0.14 (280- 315 nm) Avg. % T 0.32 0.82 2.85 1.91 5.24 0.57 0.46 0.13 (316- 380 nm)
  • the solids content of these lenses are shown on a dry basis.
  • the hydrated lenses had a water content as shown in the table.
  • the lenses were made by placing the monomer formulation in to the contact lens mold at 70° C. for 30 minutes, then ramping up to 120° C. over 10 minutes and holding for 30 minutes. The lenses were cooled down and cycled through an autoclave in saline solution.
  • % Weight Ingredient 6a 6b 6c 6d MMA 29.88 NVP 69.34 AMA 0.15 (SAME) Vazo 64 0.89 BP 0.90 0.90 0.90 0.90 BZT 0.40 0.80 — — UVAM — — 0.80 1.60 % H 2 O (after hydration) 77 76 72 68 Avg. % T 5.6 4.0 1.6 0.09 (280-315 nm) Avg. % T 17.5 9.2 9.3 0.54 (316-380 nm)
  • a stock solution of the above polymer base ingredients was prepared, and varying amounts of Tinuvin-326 and MBP were added to separate portions of the polymer base to individually obtain formulae 7a-7f.
  • Rods were filled and warmed at 48° C. for 24 hours; then cured at 110° C. for 24 hours. The rods were annealed by ramping the temperature to 110° C. over 2 hours and holding for 70 hours, then cooling over a 2 hour period. The rods were irradiated with 1.0 mRad from a Co-60 source. The rods were sliced into buttons and then machined and polished into 8 mm diameter lenses. Five lenses for each UV absorber formulation, Example 7a through 7f, were measured for UV absorption. The results were averaged and listed above.
  • a polymer base was prepared according to the following shown on a total wet basis:
  • the resulting contact lenses had average transmittance values of 6.8% for 280-315 nm (UVB) and 2.1% for 316-380 nm (UVA). At 280 nm, the transmittance was 18.72%, which is equivalent to 0.73 Absorbance units.
  • UV-blocking monomers BP and BZT
  • BP and BZT were used individually and in combination at the same levels to make molded experimental RGP lenses.
  • the averaged percent transmission data in the UVA and UVB range are reported below.
  • Lens 9c-1 Lens 9c-2 Ingredient (Actual Wt. (g)) (Actual Wt. (g)) MMA 36.774 48.774 MMA/D + C 10.003 10 DMA 50.078 40.078 BP 1.001 1.003 BZT 1.505 1.506 AZBN 0.304 0.301 EGDMA 0.358 0.355
  • Lenses were filled on a LCCM type filler/sealer using hand filling of cavities. Lenses were hydrated and processed as follows:
  • This polymerization is a thermal cure using AZBN (or AIBN, Vazo 64, etc.).
  • AZBN or AIBN, Vazo 64, etc.
  • the lenses were hydrated after polymerization.
  • UV/V spectra was run using a Perkin-Elmer spectrophotometer fitted with an integrating sphere detector. The percent transmissions of the different lens formulations were averaged over the UVA and UVB region and listed in categories according to UV monomer composition, as shown below.

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Eyeglasses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paints Or Removers (AREA)
  • Prostheses (AREA)
  • Optical Filters (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A contact lens with enhanced UV blocking to meet ANSI Class 1 specifications includes enhanced effective amounts of two different UV absorbing compounds. One UV absorber is a benzotriazole derivative, and the other UV absorber is a benzophenone derivative.

Description

    BACKGROUND OF THE INVENTION
  • This invention relates to transparent plastic materials for optical use, and particularly to ocular devices which absorb ultraviolet radiation, and to their production from ultraviolet absorbing compounds, such as by copolymerizing the compounds with suitable reactive monomers. [0001]
  • Contact lenses containing compounds for blocking ultraviolet (“UV”) light have been on the market for several years. Such lenses are useful to all who live in areas where bright sunlight is common. As UV radiation is likely to be a cause of cataracts and senile macular degeneration, everyone who wears contact lenses can benefit from the type which block this radiation. Younger persons, whose eye lenses transmit more ultraviolet radiation than do those of older persons, also should be concerned with providing additional protection. [0002]
  • Ultraviolet blocking lenses are especially useful for those who have had the natural lens of the eye removed, since the natural lens has UV absorption properties that help to protect the interior of the eye. Hence, UV absorbing intraocular lenses (IOLs) are also highly desirable, since such lenses are implanted in place of the eye's natural lens. [0003]
  • Loshaek discovered the use of polymerizable UV absorbing compounds for producing contact and intraocular lenses in the early 1970's, e.g., as shown in U.S. Pat. No. Re. 33,477. More recently, substituted 2-phenyl benzotriazole compounds having a polymerizable acrylic group have been used to produce contact lenses, e.g., as in U.S. Pat. No. 4,716,234 to Dunks et al. The UV absorption technology has been applied primarily to rigid, gas permeable lenses, most commercially available soft lenses do not contain UV absorbers. [0004]
  • Hydrogels are desirable for use in lenses, particularly IOLs. However, because of their hydrophilic nature and expanded structure, it has been difficult to incorporate UV absorbing compounds into hydrogels. Prior art UV absorbers are generally hydrophobic and have limited solubility in hydrogels. Due in part to this limited solubility, it has been difficult to copolymerize UV absorbers with hydrogel forming monomers. UV absorbers are preferably copolymerized, rather than physically entrapped within the hydrogel, to prevent the absorber from being leached out of the UV absorbing hydrogel when the hydrogel is in the aqueous environment of the eye or stored in solution. [0005]
  • In addition to problems of incorporation of UV absorbers into hydrogels, UV absorbers having the required characteristics such as UV absorption between 300-400 nm and hydrolytic stability have been difficult to synthesize. [0006]
  • Recently, Collins, et al. discovered a new class of benzotriazoles that are useful in soft contact lenses, as shown in U.S. Pat. No. 5,637,726. The compounds absorb UV light very well at the upper end of the UV spectrum. These benzotriazoles copolymerize well into hydrogel polymers without the problems of leaching out. Also, effective amounts of these benzotriazoles incorporated into the contact lens polymer do not negatively affect the properties of the polymer. Also, these compounds increase the refractive index and optic potential of the contact lenses, allowing for thinner lenses with enhanced oxygen permeability. These compounds also have a higher cut-off, up to 400 nm, to block more light in the UVA range. [0007]
  • While contact lenses containing a UV absorbing compound are now commercially available, these lenses do not block all of the UV light from entering the eye, and typically only block about 90% of the entire UV range. The UV range is generally broken in to two subranges, known as UVA and UV B. ANSI Class 1 specifications for UV absorption require an average percent transmittance of less than 1.0% at 280-315 nm (UVB range) and only less than 10% at 316-380 nm (UVA range). Commercially available UV absorbing contact lenses do not meet this standard. [0008]
  • The difficulty in obtaining a UV blocking contact lens that meets Class 1 standards by using a benzotriazole, as described by Collins et al., is that one has to use so much benzotriazole that the lens also absorbs significant amount of light at the upper end of the UVA range and into the visible light range. This results in an observable yellowish tint in the contact lens, which is not appealing to consumers. More importantly, this yellowish tint throws off the cosmetic appearance of colored contact lenses. In addition, too much benzotriazole, or other UV absorbing compound, can adversely affect the properties of the lens polymer, such as durability, flexibility, hydrophilicity, stability to sterilizing regimes, etc. Also, the compound may be present in too high quantities for all of it to covalently bond with the other monomers during the polymerization, resulting in excessive residual monomer content that may gradually leach out during use. [0009]
  • Hung et al., U.S. Pat. No. 4,963,160, proposes a solution to some of these problems by bonding two different UV absorbing compounds that each have a different UV absorbing spectra onto a triazine derivative, which is then applied as a coating onto a polymeric lens. The UV absorbers are preferably selected to provide a UV absorbing agent with the broadest UV absorption range possible. Hung et al. disclosed embodiments of these UV absorbing agents that include p-aminobenzoic acid and a benzotriazole, or p-aminobenzoic acid and a benzophenone. The use of this UV absorbing agent has certain limitations because the UV absorbing compounds can only be used in a one-to-one mole ratio, so that the UV absorption spectra of the lens cannot be optimized Also, there are difficulties to achieve consistent coating thicknesses. [0010]
  • SUMMARY OF THE INVENTION
  • The present invention overcomes some of these problems unsolved by prior art UV blocking lenses by providing a plastic material, preferably in the form a of an ocular device such as a contact lens or an intraocular lens, comprising a polymer formed by incorporating one or more monomers suitable for use in making such lenses, and effective amounts of a combination of a first ultraviolet absorber and a second ultraviolet absorber, wherein the first UV absorber is a benzotriazole compound represented by the formula: [0011]
    Figure US20010025198A1-20010927-C00001
  • where R[0012] 1a, R1b, and R1c are independently hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; R2 is hydrogen, lower alkyl, preferably tert-butyl, aryl or substituted aryl; R3 is hydrogen, lower alkyl, aryl, substituted aryl, or R4-R5-R6, where R4 is an oxygen or is absent, R5 is a linking group selected from —(CH2)nO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)nOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; R6 is acrylate, methacrylate, styrene or vinyl; and n is 2 or 3;
  • and wherein the second UV absorber is a substituted 2-hydroxy-benzophenone according to the formula: [0013]
    Figure US20010025198A1-20010927-C00002
  • where R[0014] 7a, R7b, and R7c are independently hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; R8 is a linking group selected from alkyl, —(CH2)mO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)mOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; and R9 is alky, acrylate, methacrylate, styrene or vinyl; and m is 2 or 3.
  • Other aspects and advantages of the present invention will be apparent from the following detailed description.[0015]
  • BRIEF DESCRIPTION OF THE DRAWING
  • FIG. 1 shows the UV transmission spectra from the formulations of Example 5.[0016]
  • DETAILED DESCRIPTION OF THE DRAWING AND PREFERRED EMBODIMENTS OF THE INVENTION
  • In the following description and claims, the term “percent” will be used to represent percentage by weight, unless the context indicates otherwise. [0017]
  • Ocular devices contemplated in connection with the present invention include, without limitation, windows, lenses for eyeglasses and instruments such as binoculars, goggles, face shields, contact lenses, intraocular lenses and the like. Contact lenses can include both those for correcting defective visual acuity and the so-called “bandage lenses” which are used in treating eye disorders, as well as the purely cosmetic lenses used for purposes such as changing the apparent eye color. [0018]
  • For convenience, the following acronyms and abbreviations are used to describe the below-identified compounds, unless otherwise noted: [0019]
  • A. UV Absorbing Compounds [0020]
  • 1. BZT [0021]
  • 2-(2′-hydroxy-3′-tert-butyl-5′-(3″-(4′″-vinylbenzoxy)propoxy)phenyl)-5-methoxy-2H-benzotrizole; C[0022] 29H33N3O4
  • 2. UVAM [0023]
  • 2-(2′-hydroxy-3′-tert-butyl-5′-vinylphenyl)-5-chloro-2H-benzotrizole; C[0024] 18H18CIN3O
  • [0025] 3. BP
  • 2-hydroxy-4-acryloxyethoxy-benzophenone; C[0026] 18H16O5
  • 4. MBP [0027]
  • 2-hydroxy4-methoxy-benzophenone; C[0028] 14H12O3
  • B. Lens Monomers and Structures [0029]
  • 1. HEMA; Hydroxyethyl methacrylate; C[0030] 6H10O3
  • CH[0031] 2═C(CH3)CO2CH2CH2OH
  • 2. EOEMA; Ethoxyethyl methacrylate; C[0032] 8H14O3
  • CH[0033] 2═C(CH3)CO2CH2CH2OCH2CH3
  • 3. EDMA; Ethyleneglycol dimethacrylate; C[0034] 10H14O4
  • [CH[0035] 2═C(CH3)CO2CH2—]2
  • 4. MAA; Methacrylic acid; C[0036] 4H6O2
  • CH[0037] 2═C(CH3)CO2H
  • 5. NVP; N-vinyl pyrrolidone; C[0038] 6H9NO
  • (CH[0039] 2)3C(O)N—CH═CH2
  • 6. AMA; Allyl methacrylate; C[0040] 7H10O2
  • CH═C(CH[0041] 3)CO2CH2CH═CH2
  • 7. MMA; Methyl methacrylate; C[0042] 5H8O2
  • CH[0043] 2═C(CH3)CO2CH3
  • 8. DMA; N,N-Dimethylacrylamide; C[0044] 5H9NO
  • CH[0045] 2═CHC(O)N(CH3)2
  • 9. GMA; Glyceryl methacrylate; C[0046] 6H12O4
  • CH═C(CH[0047] 3)CO2CH2CH(OH)CH2OH
  • 10. TEGDMA; Tetraethylene glycol dimethacrylate, [0048]
  • CH[0049] 2═C(CH3)COOCH2(CH2OCH2)3CH2OOC(CH3)C═CH2
  • 11. Polymerization initiators [0050]
  • VAZO 64; 2,2′-azobis(2-methylpropanenitrile); C[0051] 8H12N4
  • [C(CH[0052] 3)2(CN)—N═]2
  • VAZO 52; 2,2′-azobis(2,4-dimethylpentanenitrile); C[0053] 14H24N4
  • [C(C[0054] 4H9)(CH3)(CN)—N═]2
  • tBPP; t-Butyl peroxypivalate; C[0055] 9H12O3
  • (CH[0056] 3)CO2C(O)C(CH3)3
  • IPP; Isopropylperoxydicarbonate; C[0057] 8H14O6
  • [(CH[0058] 3)2CHOC(O)O—]2
  • The present invention includes a contact lens, intraocular lens, or an optical quality plastic comprising a polymer formed by incorporating one or more monomers suitable for use in making such lenses, and effective amounts of a first ultraviolet absorber and a second ultraviolet absorber to provide amounts of UV absorption to meet ANSI Class 1 specifications without creating an observable yellowish tint to the lens, wherein the first UV absorber is a benzotriazole compound represented by the formula: [0059]
    Figure US20010025198A1-20010927-C00003
  • where R[0060] 1a, R1b, and R1c are independently hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; R2 is hydrogen, lower alkyl, preferably tert-butyl, aryl or substituted aryl; R3 is hydrogen, lower alkyl, aryl, substituted aryl, or R4-R5-R6, where R4 is an oxygen or is absent, R5 is a linking group selected from —(CH2)nO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)nOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; R6 is acrylate, methacrylate, styrene or vinyl; and n is 2 or 3;
  • and wherein the second UV absorber is a substituted 2-hydroxy-benzophenone according to the formula: [0061]
    Figure US20010025198A1-20010927-C00004
  • where R[0062] 7a, R7b, and R7c are independently hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; R8 is a linking group selected from alkyl, —(CH2)mO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)mOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; and R9 is alkyl, acrylate, methacrylate, styrene or vinyl; and m is 2 or 3.
  • For the first UV absorber, the benzotriazole derivatives, preferred substituent groups for R[0063] 1 are H, Cl and CH3O—, more preferably CH3O—. Preferably, R1a and R1c are hydrogen when R1b is methoxy. The preferred substituent group for R2 is tert-butyl. R3 is preferably oxygen. R4 is preferably oxygen. R5 is preferably selected from —(CH2)3OCH2— and —(CH2)2OCH2—, more preferably R5 is —(CH2)3OCH2—. R6 is preferably methacrylate or styrene. The more preferred compound is one wherein R1 is CH3O—; R2 is —C(CH3)3; R4 is O; R5 is —(CH2)3OCH2—; and R6 is styrene. The aryl group may optionally be substituted with halogen, alkyl, halogenated alkyl, alkoxy, alkenyl, alkynyl, and amino groups.
  • Generally, benzotriazole derivatives that have UV absorbing qualities comparable to those described specifically in this application, may be useful alternatives to those defined by this invention. One skilled in the art may be able to find or synthesize such compounds and apply them in accordance with the teaching of this invention without undue experimentation. [0064]
  • A preferred class of benzotriazole compounds are represented by the formula: [0065]
    Figure US20010025198A1-20010927-C00005
  • where R[0066] 1 and R5 are as defined above.
  • Specifically, some of the preferred benzotriazole compounds of this invention are prepared following the procedures described in U.S. Pat. No. 5,637,726, to Collins et al., incorporated herein by reference. For example, reacting a vinylbenzyl chloride with a 2-[2′-hydroxy-5′-(gamma-hydroxyalkoxy)-3′-t-butylphenyl]-5-(alkoxy [or halo])-2H-benzotriazole one obtains the compound of the above formula. The starting benzotriazole can be prepared by the method described in Examples 1-3 of U.S. Pat. No. 4,716,234 to Dunks et al., which is incorporated herein by reference, substituting 4-halo-2-nitroaniline for the 4-methoxy-2-nitroaniline when it is desired to make a halogen group, and using any of 3-chloro-1-propanol, 2-chloroethanol, 2-chloro-1-propanol or 1-chloro-2-propanol to produce the desired group for R[0067] 2. Those skilled in the art will be aware of other groups which can be substituted for these chloro groups, such as other halogens, and for groups such as methoxy. By appropriate choice of the substituted nitroaniline, R1 can be made to occupy ring positions other than that shown in the above structural formula
  • Alternatively, the first UV absorbing compound may preferably be a benzotriazole derivative represented by the formula: [0068]
    Figure US20010025198A1-20010927-C00006
  • where R[0069] 1 is a hydrogen, halogen or lower alkoxy; R2 and R3 are independently hydrogen or lower alkyl. Preferably, R1 is halogen, with chlorine being more preferred. Preferably, R2 and R3 are independently hydrogen, methyl or tert-butyl. More preferably, R2 is tert-butyl. The non-polymerizable benzotriazole derivative of this formula is preferably used for rigid gas permeable contact lenses. A preferred compound is 2-(2′-hydroxy-3′-tert-butyl-5′-methyl-phenyl)-5-chlorobenzotriazole, which is manufactured by Ceiba-Geigy Corp., and commercially available under the trademark TINUVIN-326.
  • For the second UV absorbers, the benzophenone compounds, preferably R[0070] 7 is hydrogen, halogen or alkoxy. More preferably, R7 is hydrogen or p is zero. R8 is preferably alkyl, —(CH2)nO—, or absent. R9 is preferably is alkyl, acrylate, or methacrylate. The second UV absorbers are selected from the group exemplified by 2-hydroxy4-acryloxyethoxy-benzophenone, 2-hydroxy4-methacryloxy-benzophenone, and 2-hydroxy4-methoxy-benzophenone. More preferably, the selected compounds are 2-hydroxy4-acryloxyethoxy-benzophenone or 2-hydroxy4-methacryloxy-benzophenone. Most preferably, 2-hydroxy-4-acryloxyethoxy-benzophenone is selected for use in hydrogel lenses. For rigid gas permeable contact lenses or other rigid plastics, it is preferred to use 2-hydroxy-4-methoxy-benzophenone. These compounds are well-known and described, and are either commercially available or easily synthesized.
  • Typically, useful amounts of the UV absorbing compounds in a polymer range from about 0.01 percent to about 25 percent, depending upon the intended use for the polymer. In general, it will be desirable to minimize the amount of compound used, so that the physical and chemical properties of the base polymer (other than UV absorption) will not be significantly or detrimentally effected. For contact and intraocular lenses made primarily from acrylate and methacrylate polymers, about 0.05 to about 10 percent of UV absorbers can be used. For creating lenses that meet Class 1 specifications and do not have observable yellowish tints, less than 0.4 percent of the first UV absorbing compound (benzotriazole) may be used. The preferred total amounts of UV absorbers are between about 0.8 and about 3.0 percent, with between about 1.0 and about 2.0 percent being more preferred. The desired ratio of the amount of the first UV absorber to the second UV absorber (e.g. BZT:BP) is between about 5:1 and about 1:3, preferably between about 3:1 and 1:3. [0071]
  • The amounts of the individual UV absorbing compounds used depend on the polymer base, thickness of the lens, water or solids content and desired level of UV absorption. The preferred amounts will, of course, vary depending upon the water content and thickness of the lenses. For example, a lens that is twice as thick will need only half the concentration of UV absorber, assuming its water content is the same. On the other hand, a lens twice as thick with doubled water content will require the same concentration of UV absorber. [0072]
  • In practice, the first and second UV absorbers are present in amounts to provide an enhanced reduction in the level of UV transmission compared to the level of UV transmission than can be achieved by using the same total amount of one UV absorbing compound alone. In other words, the two UV absorbing compounds in combination enhance the total effective UV light blockage. Greater blocking of UV light can be achieved using lesser total amounts of the combination of BZT and BP than using a like amount of either BZT or BP alone. [0073]
  • The UV absorbing compounds can be copolymerized with a large number of unsaturated and other monomers to produce polymers having enhanced UV blocking properties. Representative useful monomers include, without limitation: [0074]
  • (a) olefins, either straight- or branched-chain, including ethylene, propene, butenes, pentenes and the like; [0075]
  • (b) dienes, such as butadiene, and trienes; [0076]
  • (c) styrene and substituted styrenes; [0077]
  • (d) silanes; [0078]
  • (e) halogen-containing vinyl or vinylidene compounds, vinyl alcohols or esters, and the like; [0079]
  • (f) acrylic and methacrylic acids, esters, amides, nitriles and the like; [0080]
  • (g) silicon substituted alkyl or aryl acrylic or methacrylic esters, including alkyl silicates; [0081]
  • (h) fluorinated alkyl or aryl substituted acrylic or methacrylic esters; [0082]
  • (i) vinyl pyrrolidones; [0083]
  • (j) vinyl silanes; [0084]
  • (k) vinyl sulfones; [0085]
  • (l) reactive mixtures of polyamines or polyhydroxy compounds and polybasic acids; [0086]
  • (m) epoxides, alkylene oxides or ethers; [0087]
  • (n) alkylidene or phenylene oxides; [0088]
  • (o) reactive mixtures of carboxylic or carbonic acids and polyhydroxy compounds; and [0089]
  • (p) reactive mixtures of isocyanates and polyhydroxy compounds. [0090]
  • Those skilled in the art will recognize that various of the monomers and reactive mixtures listed above, as well as others, can be copolymerized, and that the compounds of this invention can be used to form UV absorbing polymers with such mixtures of monomers. Copolymers which are formed may be random, block or grafted polymers. [0091]
  • In addition to incorporating the compounds into polymers by copolymerization, it is possible to form a new WV absorbing polymer structure by condensing or otherwise coupling absorbing compounds with a polymerized material having pendant reactive groups, or to form a WV absorbing polymer by physically dispersing the compounds as additives in a formed polymer, e.g., adding a compound to a polymer melt, provided that the ratio of the different UV absorbing compounds in the polymer can be adjusted to achieve the desired enhanced UV blocking. [0092]
  • Hydrogels for use in contact lenses or IOLs ideally should contain a UV absorbing compound. This is particularly the case when the lens is to be used to replace the natural lens of the eye lost to injury or disease. The present invention is directed to UV absorbing hydrogels having the following characteristics. [0093]
  • First, the UV absorbing monomer of the UV blocking hydrogel should block UV radiation between about 300-400 nm, because the purpose of incorporating a UV absorber into a hydrogel is to prevent transmittance of UV radiation to the retina. As previously discussed, this function is normally performed by the eye's natural lens, which, however, is damaged by UV radiation. Although the UV blocking hydrogel should block UV radiation between about 300 to 400 nm, it is desirable that absorbance sharply decrease above 400 nm. If absorbance does not sharply decrease above 400 nm, the UV absorbing hydrogel will take on a significant yellow tint. In some cases, however, some yellow tint may be desired. For example, it has been thought that increased light absorbance in this range by spectacles, goggles, contact lenses, etc., enhances visual acuity. [0094]
  • Second, it is desirable to incorporate a UV absorbing monomer into the hydrogel at the lowest concentration possible in order to minimize the impact of the compound on the structure of the hydrogel. Hydrogels are particularly susceptible to being adversely affected by the addition of other compounds due to their expanded structure. Most UV absorbing monomers with good UV absorbing characteristics are more hydrophobic than hydrogel-forming monomers. The addition of any significant amount of a UV absorbing monomer to a hydrogel forming monomer decreases the water content of the resulting UV absorbing hydrogel. This can adversely impact the desirable properties of the hydrogel. Therefore, it is desirable to use at least two different UV absorbing compounds which in combination have an enhanced effective blocking of UV radiation, thereby minimizing the concentration of absorber required. [0095]
  • Third, it is important the UV absorbing hydrogel be stable as a copolymer and in particular exhibit long-term hydrolytic stability. This is a particularly important requirement when the hydrogel is to be used as an IOL and surgically implanted within the eye, since IOLs are generally intended to remain in the eye indefinitely. [0096]
  • Fourth, the UV absorbing compound to be incorporated into the hydrogel must be soluble in the hydrogel-forming monomer so that it can be copolymerized with the hydrogel-forming monomer. It is necessary that the UV absorber be copolymerized with the hydrogel-forming monomer due to the expanded nature of hydrogels. Because of this expanded structure it is impractical to rely on imbedding or dispersing UV-absorbing compounds within the hydrogel as can be done with rigid-gas-permeable (RGP) type lenses. Moreover, copolymerization prevents the UV absorber from being leached from the hydrogel while in the eye or in a storage solution. At a minimum, the UV absorbing monomer should be soluble in the hydrogel forming monomer in an amount sufficient to provide the desired degree of UV absorbance in the UV blocking hydrogel. [0097]
  • Ocular devices or UV blocking optical plastics, in accordance with the invention, may be produced by incorporating a first UV absorbing compound, a second UV absorbing compound, and at least one monomeric compound suitable for producing an ocular device, preferably in the case of contact and intraocular lenses, hydroxyethyl methacrylate, N-vinyl pyrrplidone, alkyl methacrylates such as methyl methacrylate, aryl methacrylates, silicone methacrylate, glyceryl methacrylate, fluorinated methacrylates, alkyl substituted styrene, or combination thereof. Of course, other lens-producing monomers may be used. [0098]
  • Contact and intraocular lenses in accordance with invention may be hydrophilic, hard, or rigid-gas-permeable (RGP), depending on the monomer or combination thereof in which the UV-absorbing compounds of the invention are incorporated. In the case of hard or RGP lenses, it is preferred to have the UV absorbers dispersed in the polymer matrix. In the case of hydrophilic lenses, it is preferred to have the UV absorbers copolymerized with the base lens monomers. [0099]
  • Copolymerization may take place by any of the methods well known within the ocular device industry, e.g., by heat or UV light, or with a suitable initiator. Polymerization temperatures are typically 25° to 140° C., more preferably 30° to 100° C., for 5 minutes to 96 hours, more preferably 1 to 24 hours. Suitable polymerization catalysts include azobisisobutyronitrile, available from E. I. DuPont de Nemours Corporation, Wilmington, Del. U.S.A. as Vazo 64™, 2,2′-azobis (2,4-dimethylpentanenitrile), available from DuPont as Vazo 52™m, and 2,5-dimethyl-2,5-bis(2-ethylhexanoylperoxy) hexane, available from Elf-Atochem, Buffalo, N.Y. U.S.A. as Lupersol 256™, as well as other peroxides. [0100]
  • If UV light is used to initiate the polymerization, its intensity should be about 0.1 to about 50 milliwatts per square centimeter, more preferably 1 to 5 mW/cm[0101] 2. Generally, the time required is from 1 minute to 10 hours, preferably from 5 minutes to 2 hours. The temperature is between about 20 and 50° C., preferably 25-30° C. Light-created radicals are derived from the initiators such as Vazo 52 and the like.
  • Lenses of the invention may also be produced by first polymerizing a rod of the copolymer, cutting the rod into bonnets or buttons, and machining the bonnets or buttons into lenses, as is well known in the art. If the polymer undergoes a UV cure, the monomer mixture may also be heat cured after exposure to the UV source. Alternatively, the lenses may be produced by any of the known molding or casting techniques, such as the methods referred to by Kindt-Larsen et al. in U.S. Pat. No. 5,039,459. The exact manner used for polymerization and lens shaping is a matter of choice and is not critical to this invention. [0102]
  • The following examples further describe the invention, but are not to be construed as limiting the scope of the invention. Generally, unless otherwise noted, the relative amounts of ingredients are shown on a dry weight basis. In examples where the total ingredients do not total exactly 100 percent or 1.000 fraction, the amount of ingredients should be considered to be approximate relative proportions. [0103]
  • EXAMPLE 1
  • HEMA Based Class I Lens [0104]
    Ingredient Weight Fraction of Polymer Base
    HEMA 0.5788
    EOEMA 0.0647
    EDMA 0.0148
    MAA 0.0106
    BZT 0.0044
    BP 0.0096
    IPA (Isopropyl alcohol) 0.3099
    Vazo 52 0.0072
    TOTAL 1.0000
  • The hydrated lens had a water content of 53% with a center thickness of 0.083 mm. The average light transmission was %T(280-315nm)=0.02% and %T(315-380 nm)=2.2%. [0105]
  • EXAMPLE 2
  • NVP Based Class I Lens [0106]
    Ingredient Weight Fraction
    MMA 0.2954
    NVP 0.6743
    AMA 0.0016
    BZT 0.0063
    BP 0.0136
    Vazo 64 0.0088
    TOTAL 1.0000
  • The hydrated lens had a water content of 74% [0107]
  • EXAMPLE 3
  • GMA-Based Class I Lens [0108]
    Ingredient Weight Fraction
    GMA 0.6897
    MMA 0.2871
    EDMA 0.0034
    BZT 0.0062
    BP 0.0134
    IPP 0.0002
    TOTAL 1.0000
  • The hydrated lens had a water content of 38% [0109]
  • EXAMPLE 4
  • GMA/MMA-Based Class I Lens [0110]
    Ingredient Weight Fraction
    GMA 0.5282
    MMA 0.4303
    Water 0.0196
    EDMA 0.0010
    BZT 0.0062
    BP 0.0137
    tBPP 0.0010
    TOTAL 1.0000
  • EXAMPLE 5(a-h)
  • HEMA-Based Lenses [0111]
    % Weight
    Ingredient 5a 5b 5c 5d 5e 5f 5g 5h
    HEMA 52.912 (SAME)
    EOEMA 05.727
    IPA 37.00
    EDMA 01.618
    MAA 1.057
    Vazo-52 0.336
    Lupersol 256 0.331
    BZT 1.0 0.75 0.5 0.5 0.5 0.75 0.75 1.0
    BP* 0.5 0.5 0.5 0.5 0.75 0.75
    Methyl- 0.5 0.5 0.75 1.0
    BZT**
    % H2O 49 51 50 49 50 48 47 48
    Avg. % T 0.45 0.92 2.26 0.25 1.23 0.34 0.25 0.14
    (280-
    315 nm)
    Avg. % T 0.32 0.82 2.85 1.91 5.24 0.57 0.46 0.13
    (316-
    380 nm)
  • The solids content of these lenses are shown on a dry basis. The hydrated lenses had a water content as shown in the table. The lenses were made by placing the monomer formulation in to the contact lens mold at 70° C. for 30 minutes, then ramping up to 120° C. over 10 minutes and holding for 30 minutes. The lenses were cooled down and cycled through an autoclave in saline solution. [0112]
  • The UV transmission spectra for the lenses of Examples 5a through 5h are shown in FIG. 1. [0113]
  • EXAMPLE 6(a-d)
  • [0114]
    % Weight
    Ingredient 6a 6b 6c 6d
    MMA 29.88
    NVP 69.34
    AMA 0.15 (SAME)
    Vazo 64 0.89
    BP 0.90 0.90 0.90 0.90
    BZT 0.40 0.80
    UVAM 0.80 1.60
    % H2O (after hydration) 77 76 72 68
    Avg. % T 5.6 4.0 1.6 0.09
    (280-315 nm)
    Avg. % T 17.5 9.2 9.3 0.54
    (316-380 nm)
  • EXAMPLE 7 (a-f)
  • RGP lenses [0115]
    % Weight Polymer Base
    Ingredient 7a 7b 7c 7d 7e 7f
    TPMD 40.00
    MMA 54.77
    MAA 5.00 (SAME)
    TEGDMA 0.10
    TBPP 0.13
    D&C Green #6 0.00715
    Dye
    TINUVIN-326 0.06 0.75 0.50 0.75 0.82 0.90
    MBP 0.15 0.15 0.15
    Avg. % T 0.82 1.50 0.89 0.41 1.02 0.91
    (280-315 nm)
    Avg. % T 1.09 0.39 1.17 0.34 0.23 0.15
    (316-380 nm)
  • A stock solution of the above polymer base ingredients was prepared, and varying amounts of Tinuvin-326 and MBP were added to separate portions of the polymer base to individually obtain formulae 7a-7f. Rods were filled and warmed at 48° C. for 24 hours; then cured at 110° C. for 24 hours. The rods were annealed by ramping the temperature to 110° C. over 2 hours and holding for 70 hours, then cooling over a 2 hour period. The rods were irradiated with 1.0 mRad from a Co-60 source. The rods were sliced into buttons and then machined and polished into 8 mm diameter lenses. Five lenses for each UV absorber formulation, Example 7a through 7f, were measured for UV absorption. The results were averaged and listed above. [0116]
  • EXAMPLE No. 8
  • HEMA-based UV comparison [0117]
  • Example8(a)
  • A polymer base was prepared according to the following shown on a total wet basis: [0118]
  • HEMA49.491%, EOEMA-4.97%, APM-0.08%, IPA-42.10%, EDMA-1.20%, MAA-4.0590, Vazo 52-0.028%, BZT-0.82%. This amount of BZT added is equivalent to 1.42% by weight of dry polymer. The resulting contact lenses had average transmittance values of 6.8% for 280-315 nm (UVB) and 2.1% for 316-380 nm (UVA). At 280 nm, the transmittance was 18.72%, which is equivalent to 0.73 Absorbance units. [0119]
  • Example 8(b)
  • To the same polymer base as above 0.75% BZT and 0.79% BP on a dry basis was added, for a total of 1.54% UV absorbers on a dry weight basis. The resulting contact lenses had average transmittance values of 1.03-% for 280-315 nm (UVB) and 4.07% for 316-380 nm (UVA). At 280 nm, the transmittance was 1.89%, which is equivalent to 1.72 Absorbance units. [0120]
  • Comparison of Examples 8(a) and 8(b)
  • Based on the results of 8(a), one can calculate the amount of BZT needed to obtain the same absorbance as was obtained in 8(b) using a mixture of BZT and BP. Using Beer's Law, the following equation is used % BZT (8a)×Abs(8b)/Abs(8a)=% BZT. Plugging in the numbers as follows: 1.42%×1.72/0.73 equals 3.35% BZT on a dry basis is calculated to obtain 1.89% transmittance at 280nm. This is more than double the total amount by weight of combined UV absorbers used in Ex. 8(b). [0121]
  • Example 8(c)
  • To the same polymer base as above 0.64% BZT and 0.1.39% BP on a dry basis was added, for a total of 2.03% UV absorbers on a dry weight basis. The resulting contact lenses had average transmittance values of 0.15% for 280-315 nm (UVB) and 3.67% for 316-380 nm (UVA). At 280 nm, the transmittance was 0.249%, which is equivalent to 2.62 Absorbance units. [0122]
  • Comparison of Examples 8(a) and 8(c)
  • Based on the results of 8(a), one can calculate the amount of BZT needed to obtain the same absorbance as was obtained in 8(c) using a mixture of BZT and BP. Again, using Beer's Law, one can calculate the amount of BZT needed as follows: 1.42%×2.62/0.73 equals 5.10% BZT on a dry basis is calculated to obtain 1.89% transmittance at 280 nm. This is more than 2.5 times the total amount by weight of combined UV absorbers used in Ex. 8(c). [0123]
  • Example No. 9
  • DMA/MMA-based lenses Comparative Example [0124]
  • In this example, UV-blocking monomers, BP and BZT, were used individually and in combination at the same levels to make molded experimental RGP lenses. For comparison, the averaged percent transmission data in the UVA and UVB range are reported below. [0125]
  • Target Formulations for Examples 9a and 9b
  • [0126]
    UV DMA/MMA AIBN BP BZT
    Lens IMT Blocker Ratio IMT wt % wt % wt %
    9a-1 D&C* BP 1.07:1 75 ppm 0.30 1.00
    9b-1 D&C BZT 1:07:1 75 ppm 0.30 1.50
    9a-2 APM** BP 1.07:1 75 ppm 0.30 1.00
    9b-2 APM BZT 1.07:1 75 ppm 0.30 1.50
  • Formulation Information for Example 9c
  • [0127]
    Lens 9c-1 Lens 9c-2
    Ingredient (Actual Wt. (g)) (Actual Wt. (g))
    MMA 36.774 48.774
    MMA/D + C 10.003 10
    DMA 50.078 40.078
    BP  1.001 1.003
    BZT  1.505 1.506
    AZBN  0.304 0.301
    EGDMA  0.358 0.355
  • Lens Preparation [0128]
  • Lenses were filled on a LCCM type filler/sealer using hand filling of cavities. Lenses were hydrated and processed as follows: [0129]
  • Cure was carried out in a Gallenkamp oven as follows: [0130]
  • Nitrogen purge for 1 hour at ambient conditions [0131]
  • Ramp to 72° C. at 45° C. hour [0132]
  • Dwell at 72° C. for one hour [0133]
  • Ramp to 124° C. at 45° C. hour [0134]
  • Dwell at 124° C. for 48 minutes [0135]
  • Off [0136]
  • This polymerization is a thermal cure using AZBN (or AIBN, Vazo 64, etc.). The lenses were hydrated after polymerization. [0137]
  • The UV/V spectra was run using a Perkin-Elmer spectrophotometer fitted with an integrating sphere detector. The percent transmissions of the different lens formulations were averaged over the UVA and UVB region and listed in categories according to UV monomer composition, as shown below. [0138]
    UV Transmittance Comparison
    UV monomers(s) Ave % T Ave % T
    Example (dry weight basis) (280-315 nm) (316-380 nm)
    9a 1% BP 1.6 26.7
    9b 1.5% BZT 4.7 7.7
    9c 1% BP & 1.5% BZT 0.1 0.25
  • The data above show in a crisp way the benefit derived from combining UV blockers. Besides the predictable “covering of holes” in the UV spectrum, it is observed that an enhanced reduction in percent transmission is obtained, greater than might have been expected. [0139]
  • The invention has been described with reference to specific embodiments, which are provided only for exemplification and are not to be construed as limiting the scope of the invention as defined by the appended claims. [0140]

Claims (34)

What is claimed is:
1. A contact lens comprising a hydrogel polymer formed by polymerizing one or more monomers suitable for use in making such lenses, and incorporating effective amounts of a first ultraviolet absorber and a second ultraviolet absorber, wherein said first UV absorber is a benzotriazole compound represented by the formula:
Figure US20010025198A1-20010927-C00007
where R1a, R1b, and R1c are independently hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; R2 is hydrogen or lower alkyl, aryl or substituted aryl; R3 is hydrogen, lower alkyl, aryl, substituted aryl, or R4-R5-R6, where R4 is an oxygen or is absent, R1 is a linking group selected from —(CH2)nO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)nOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; R6 is acrylate, methacrylate, styrene or vinyl; and n is 2 or 3;
and wherein the second UV absorber is a substituted 2-hydroxy-benzophenone according to the formula:
Figure US20010025198A1-20010927-C00008
where R7a, R7b, and R7c are independently hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; R8 is a linking group selected from alkyl, —(CH2)mO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)mOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; and R9 is alkyl, acrylate, methacrylate, styrene or vinyl; and m is 2 or 3.
2. The lens of
claim 1
wherein the first UV absorber is a benzotriazole compound represented by the formula:
Figure US20010025198A1-20010927-C00009
where R1 is hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; and R5 is a linking group selected from —(CH2)nO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)nOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; and n is 2 or 3.
3. The lens of
claim 2
wherein R1 is methoxy.
4. The lens of
claim 2
wherein R5 is —(CH2)nOCH2—.
5. The lens of
claim 4
wherein n is 3.
6. The lens of
claim 1
wherein the second UV absorber is 2-hydroxy-4-acryloxyethoxy-benzophenone, 2-hydroxy-4-methacryloxy-benzophenone, or 2-hydroxy-4-methoxy-benzophenone.
7. The lens of
claim 6
wherein the second UV absorbing compound is 2-hydroxy-4-acryloxyethoxy-benzophenone.
8. The lens of
claim 1
wherein the lens has an average UV transmittance of less than 10 percent in the UVA range and an average UV transmittance of less than 1.0 percent in the UVB range.
9. The lens of
claim 8
wherein the average UV transmittance is less than 1.0 percent in the UVA range.
10. A rigid gas permeable contact lens comprising a polymer formed by incorporating a monomer suitable for use in making such lenses, and effective amounts of a first ultraviolet absorber and a second ultraviolet absorber, wherein said first UV absorber is a benzotriazole compound represented by the formula:
Figure US20010025198A1-20010927-C00010
where R1 is a hydrogen, halogen or lower alkoxy, and
R2 and R3 are independently hydrogen or lower alkyl; and
the second UV absorber is selected from the group consisting of 2-hydroxy4-acryloxyethoxy-benzophenone, 2-hydroxy-4-methacryloxy-benzophenone and 2-hydroxy4-methoxy-benzophenone.
11. The lens of
claim 10
wherein R2 and R3 are independently hydrogen, methyl or tert-butyl.
12. The lens of
claim 10
wherein R2 is tert-butyl.
13. The lens of
claim 10
wherein R1 is halogen.
14. The lens of
claim 10
wherein the first UV absorber is 2-(2′-hydroxy-3 ′-tert-butyl-5 ′-methylphenyl)-5-chlorobenzotriazole.
15. The lens of
claim 10
wherein the second UV absorber is 2-hydroxy-4-methoxy-benzophenone.
16. The lens of
claim 10
wherein the first UV absorber is 2-(2′-hydroxy-3′-tert-butyl-5′-methylphenyl)-5-chlorobenzotriazole and the second UV absorber is 2-hydroxy4-methoxy-benzophenone.
17. An intraocular lens comprising a polymer incorporating effective amounts of a first ultraviolet absorber and a second ultraviolet absorber, wherein said first UV absorber is a benzotriazole compound represented by the formula:
Figure US20010025198A1-20010927-C00011
where R1a, R1b, and R1c are independently hydrogen, halogen, C1 -C 6 straight or branched chain alkoxy group, aryl or substituted aryl; R2 is hydrogen, lower alkyl, aryl or substituted aryl; R3 is hydrogen, lower alkyl, aryl, substituted aryl, or R4-R5-R6, where R4 is an oxygen or is absent, R5 is a linking group selected from —(CH2)nO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)nOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; R6 is acrylate, methacrylate, styrene or vinyl; and n is 2 or 3;
and wherein the second UV absorber is a substituted 2-hydroxy-benzophenone according to the formula:
Figure US20010025198A1-20010927-C00012
where R7a, R7b, and R7care independently hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; R8 is a linking group selected from alkyl, —(CH2)mO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)mOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; and R9 is alkyl, acrylate, methacrylate, styrene or vinyl; and m is 2 or 3.
18. The lens of
claim 17
, wherein the first UV absorber and the second UV absorber are present in a ratio of between about 3:1 and 1:3 by weight.
19. The lens of
claim 17
, wherein the total amount of UV absorbers present is between about 0.8 and about 3.0 percent dry weight of the lens material.
20. The lens of
claim 19
, wherein the total amount of UV absorbers present is between about 1.0 and about 2.0 percent by dry weight of lens material.
21. The lens of
claim 17
, wherein the amount of the first UV absorber present is less than 0.5 percent by dry weight of lens material so as to minimize any observable yellowish tint.
22. The lens of
claim 17
wherein the first UV absorber is a benzotriazole compound represented by the formula:
Figure US20010025198A1-20010927-C00013
where R1 is hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; and R5 is a linking group selected from —(CH2)nO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)nOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; and n is 2 or 3.
23. The lens of
claim 22
wherein R1 is methoxy.
24. The lens of
claim 22
wherein R5 is —(CH 2)nOCH2—.
25. The lens of
claim 24
wherein n is 3.
26. A UV-absorbing transparent plastic material incorporating at least two UV absorbing compounds, wherein the first UV absorber is a benzotriazole compound represented by the formula:
Figure US20010025198A1-20010927-C00014
where R1a, R1b, and R1c are independently hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; R2 is hydrogen, lower alkyl, aryl or substituted aryl; R3 is hydrogen, lower alkyl, aryl, substituted aryl, or R4-R5-R6, where R4 is an oxygen or is absent, R5 is a linking group selected from —(CH2)nO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)nOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; R6 is acrylate, methacrylate, styrene or vinyl; and n is 2 or 3;
and wherein the second UV absorber is a substituted 2-hydroxy-benzophenone according to the formula:
Figure US20010025198A1-20010927-C00015
where R7a, R7b, and R7care independently hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; R8 is a linking group selected from alkyl, —(CH2)mO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)mOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; and R9 is alkyl, acrylate, methacrylate, styrene or vinyl; and m is 2 or 3.
27. The plastic material of
claim 26
wherein the first UV absorber is a benzotriazole compound represented by the formula:
Figure US20010025198A1-20010927-C00016
where R1 is hydrogen, halogen, C1-C6 straight or branched chain alkoxy group, aryl or substituted aryl; and R5 is a linking group selected from —(CH2)nO—, —CH(CH3)CH2O—, —CH2CH(CH3)O—, —(CH2)nOCH2—, —CH(CH3)CH2OCH2—, or —CH2CH(CH3)OCH2— group, or is absent; and n is 2 or 3.
28. The plastic material of
claim 27
wherein R1 is methoxy.
29. The plastic material of
claim 27
wherein R5 is —(CH2)nOCH2—.
30. The plastic material of
claim 29
wherein n is 3.
31. The plastic material of
claim 26
wherein the second UV absorber is 2-hydroxy4-acryloxyethoxy-benzophenone, 2-hydroxy-4-methacryloxy-benzophenone, or 2-hydroxy-4-methoxy-benzophenone.
32. The plastic material of
claim 26
wherein the second UV absorbing compound is 2-hydroxy4-acryloxyethoxy-benzophenone.
33. The plastic material of
claim 26
wherein the lens has an average UV transmittance of less than 10 percent in the UVA range and an average UV transmittance of less than 1.0 percent in the UVB range.
34. The plastic material of
claim 33
wherein the average UV transmittance is less than 1.0 percent in the UVA range.
US09/838,992 1998-07-21 2001-04-20 UV blocking lenses and material containing benzotriazoles and benzophenones Abandoned US20010025198A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/838,992 US20010025198A1 (en) 1998-07-21 2001-04-20 UV blocking lenses and material containing benzotriazoles and benzophenones

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/121,071 US6244707B1 (en) 1998-07-21 1998-07-21 UV blocking lenses and material containing benzotriazoles and benzophenones
US09/838,992 US20010025198A1 (en) 1998-07-21 2001-04-20 UV blocking lenses and material containing benzotriazoles and benzophenones

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/121,071 Continuation US6244707B1 (en) 1998-07-21 1998-07-21 UV blocking lenses and material containing benzotriazoles and benzophenones

Publications (1)

Publication Number Publication Date
US20010025198A1 true US20010025198A1 (en) 2001-09-27

Family

ID=22394323

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/121,071 Expired - Lifetime US6244707B1 (en) 1998-07-21 1998-07-21 UV blocking lenses and material containing benzotriazoles and benzophenones
US09/838,992 Abandoned US20010025198A1 (en) 1998-07-21 2001-04-20 UV blocking lenses and material containing benzotriazoles and benzophenones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/121,071 Expired - Lifetime US6244707B1 (en) 1998-07-21 1998-07-21 UV blocking lenses and material containing benzotriazoles and benzophenones

Country Status (12)

Country Link
US (2) US6244707B1 (en)
EP (1) EP1096905B1 (en)
JP (1) JP2002521705A (en)
KR (1) KR20010084879A (en)
CN (1) CN1317955A (en)
AT (1) ATE317250T1 (en)
AU (1) AU757384B2 (en)
BR (1) BR9912324A (en)
CA (1) CA2338245C (en)
DE (1) DE69929798T2 (en)
MX (1) MXPA01000783A (en)
WO (1) WO2000004848A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030234459A1 (en) * 2000-05-19 2003-12-25 Nandu Mahendra P. Method for the manufacture of molded polymeric devices using variable frequency microwaves
US20070055369A1 (en) * 2005-09-08 2007-03-08 Calhoun Vision, Inc Novel adjustable optical elements with enhanced ultraviolet protection
WO2012015639A1 (en) * 2010-07-30 2012-02-02 Novartis Ag Method for making uv-absorbing ophthalmic lenses
US9005700B2 (en) 2011-10-12 2015-04-14 Novartis Ag Method for making UV-absorbing ophthalmic lenses
US10338408B2 (en) 2012-12-17 2019-07-02 Novartis Ag Method for making improved UV-absorbing ophthalmic lenses
US10647874B2 (en) 2016-01-21 2020-05-12 Rohm And Haas Company Polymer dispersion for durable coating, and the coating comprising the same

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329485B1 (en) * 1998-12-11 2001-12-11 Bausch & Lomb Incorporated High refractive index hydrogel compositions for ophthalmic implants
US7879288B2 (en) * 1999-03-01 2011-02-01 Johnson & Johnson Vision Care, Inc. Method and apparatus of sterilization using monochromatic UV radiation source
JP3676138B2 (en) 1999-09-20 2005-07-27 Hoya株式会社 Plastic spectacle lens excellent in ultraviolet absorption and manufacturing method thereof
JP3547662B2 (en) * 1999-09-20 2004-07-28 Hoya株式会社 Plastic spectacle lens excellent in ultraviolet absorption and method of manufacturing the same
JP4152732B2 (en) * 2001-12-27 2008-09-17 株式会社トクヤマ Resin composition
US6851804B2 (en) * 2001-12-28 2005-02-08 Jagdish M. Jethmalani Readjustable optical elements
US20040186241A1 (en) * 2003-03-20 2004-09-23 Gemert Barry Van Photochromic ocular devices
KR100532103B1 (en) * 2003-05-27 2005-11-29 삼성전자주식회사 Lightfast additives having UV-absorbing moieties and ink composition containing the same
US7276544B2 (en) * 2003-09-08 2007-10-02 Bausch & Lomb Incorporated Process for manufacturing intraocular lenses with blue light absorption characteristics
DE10349254A1 (en) * 2003-10-20 2005-05-12 Transmit Technologietransfer Intraocular lens device for improving vision in retinal diseases
CA2552122A1 (en) 2003-12-29 2005-07-21 Advanced Medical Optics, Inc. Intraocular lenses having a visible light-selective-transmissive-region
US20060083940A1 (en) * 2004-04-30 2006-04-20 Solomon Bekele Ultraviolet light absorbing composition
US7278737B2 (en) 2004-04-30 2007-10-09 Advanced Medical Optics, Inc. Ophthalmic devices having a highly selective violet light transmissive filter and related methods
JP2006011131A (en) * 2004-06-28 2006-01-12 Asahi Kasei Aimii Kk Colored contact lens
JP5264177B2 (en) * 2004-11-22 2013-08-14 アボット・メディカル・オプティクス・インコーポレイテッド Copolymerizable methine and anthraquinone compounds and articles containing them
ATE549649T1 (en) * 2004-11-22 2012-03-15 Abbott Medical Optics Inc COPOLYMERIZABLE AZONE COMPOUNDS AND ITEMS CONTAINING THEM
US20060122293A1 (en) * 2004-12-03 2006-06-08 Rick Wilk Ultraviolet light absorber stabilizer combination
US20060197067A1 (en) * 2005-03-04 2006-09-07 Erning Xia Radiation-absorbing materials, ophthalmic compositions containing same, and method of treating ophthalmic devices
EP2568573A3 (en) 2005-03-07 2014-06-04 Black & Decker Inc. Power Tools with Motor Having a Multi-Piece Stator
US20060252850A1 (en) * 2005-05-04 2006-11-09 Bausch & Lomb Incorporated Radiation-absorbing polymeric materials and ophthalmic devices comprising same
US7842367B2 (en) 2005-05-05 2010-11-30 Key Medical Technologies, Inc. Ultra violet, violet, and blue light filtering polymers for ophthalmic applications
US7163446B1 (en) * 2005-06-20 2007-01-16 John Ray Cole Vehicle headlight restoration
CN1884364B (en) * 2005-06-23 2010-08-25 上海伟星光学有限公司 Composition for manufacturing photochromic resin lens
US20070092830A1 (en) * 2005-10-24 2007-04-26 Bausch & Lomb Incorporated Polymeric radiation-absorbing materials and ophthalmic devices comprising same
US20070092831A1 (en) * 2005-10-24 2007-04-26 Bausch & Lomb Incorporated Radiation-absorbing polymeric materials and ophthalmic devices comprising same
US7901778B2 (en) 2006-01-13 2011-03-08 Saint-Gobain Performance Plastics Corporation Weatherable multilayer film
ES2397865T3 (en) 2006-10-13 2013-03-11 Novartis Ag Intraocular lenses with single blue-violet limit and blue light transmission characteristics
US20080259617A1 (en) * 2007-04-19 2008-10-23 Wayne M. Torcivia Transportation system and method or methods for the restoration,re-manufacturing and re-conditioning or any combination thereof,of a vehicle headlight fixture or headlight fixture lens or any combination thereof
TW200916531A (en) 2007-08-09 2009-04-16 Alcon Inc Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light
TWI435915B (en) 2007-08-09 2014-05-01 Alcon Inc Ophthalmic lens materials containing chromophores that absorb both uv and short wavelength visible light
WO2009102454A1 (en) * 2008-02-12 2009-08-20 Aaren Scientific Inc. Ophthalmic lens having a yellow dye light blocking component
AU2009228847B2 (en) * 2008-03-27 2014-08-07 Alcon, Inc. Hydrogel intraocular lens and method of forming same
CN101318029B (en) * 2008-06-20 2012-02-01 周辉 Plastic macromolecule polymeric material for eyes and uses thereof
US8236053B1 (en) 2008-10-08 2012-08-07 Novartis Ag 2-amino benzophenone UV-absorbers for ophthalmic lens materials
TWI453199B (en) 2008-11-04 2014-09-21 Alcon Inc Uv/visible light absorbers for ophthalmic lens materials
SG172394A1 (en) * 2008-12-30 2011-08-29 Novartis Ag Tri-functional uv-absorbing compounds and use thereof
KR101869746B1 (en) * 2010-04-29 2018-06-21 노파르티스 아게 Intraocular lenses with combinations of uv absorbers and blue light chromophores
US8740382B1 (en) 2010-09-30 2014-06-03 Cognex Corporation System and method for automatically tracking a contact lens in a wearer's eye
US9427778B2 (en) 2010-10-20 2016-08-30 Search Automotive Technologies, Llc Headlight restoration kit
WO2012082704A1 (en) 2010-12-13 2012-06-21 Novartis Ag Ophthalmic lenses modified with functional groups and methods of making thereof
US20130313733A1 (en) * 2012-05-25 2013-11-28 Ivan Nunez Method of making a fully polymerized uv blocking silicone hydrogel lens
JP6152538B2 (en) * 2012-07-23 2017-06-28 ボシュ・アンド・ロム・インコーポレイテッドBausch & Lomb Incorporated Light absorbing compounds for optical polymers
KR20150107844A (en) 2013-01-15 2015-09-23 메디? 압쌜믹 (씨와이) 리미티드 Bioanalogic intraocular lens
US10441676B2 (en) * 2013-01-15 2019-10-15 Medicem Institute s.r.o. Light-adjustable hydrogel and bioanalogic intraocular lens
US20160221281A1 (en) 2013-09-12 2016-08-04 Battelle Memorial Institute Lens modification methods
JP6516147B2 (en) * 2015-03-03 2019-05-22 株式会社 アイレ Antibacterial contact lens, method of using the same, and method of manufacturing the same
KR20180063212A (en) * 2015-09-29 2018-06-11 비전 이즈, 엘피 Ophthalmic lenses that absorb UV and high energy visible light
CA3027646A1 (en) * 2016-06-23 2017-12-28 Medicem Institute s.r.o. Light-adjustable hydrogel and bioanalogic intraocular lens
US10752720B2 (en) 2017-06-26 2020-08-25 Johnson & Johnson Vision Care, Inc. Polymerizable blockers of high energy light
US10526296B2 (en) 2017-06-30 2020-01-07 Johnson & Johnson Vision Care, Inc. Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light
US10723732B2 (en) 2017-06-30 2020-07-28 Johnson & Johnson Vision Care, Inc. Hydroxyphenyl phenanthrolines as polymerizable blockers of high energy light
US11993037B1 (en) 2018-03-02 2024-05-28 Johnson & Johnson Vision Care, Inc. Contact lens displaying improved vision attributes
US11543683B2 (en) 2019-08-30 2023-01-03 Johnson & Johnson Vision Care, Inc. Multifocal contact lens displaying improved vision attributes
US10935695B2 (en) 2018-03-02 2021-03-02 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of UV and high energy visible light
KR102055835B1 (en) * 2018-06-04 2019-12-13 에스케이씨 주식회사 Polymerizable composition and optical material prepared therefrom
JP7368397B2 (en) * 2018-07-03 2023-10-24 ボシュ・アンド・ロム・インコーポレイテッド Water extractable ophthalmic device
WO2020032972A1 (en) * 2018-08-10 2020-02-13 Bausch & Lomb Incorporated High water content ophthalmic devices
CA3107771A1 (en) * 2018-08-10 2020-02-13 Bausch & Lomb Incorporated Ophthalmic devices
WO2020218609A1 (en) * 2019-04-26 2020-10-29 ミヨシ油脂株式会社 Ultraviolet absorber having excellent heat resistance and long-wavelength absorption
US11958824B2 (en) 2019-06-28 2024-04-16 Johnson & Johnson Vision Care, Inc. Photostable mimics of macular pigment
CN111430550A (en) * 2020-03-26 2020-07-17 杭州纤纳光电科技有限公司 Perovskite battery component with ultraviolet protection layer and preparation method thereof
US20240004105A1 (en) * 2020-09-23 2024-01-04 Griffith Altmann Refractive-index adustable lens

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2962533A (en) 1958-01-20 1960-11-29 American Cyanamid Co Ortho-hydroxybenzophenones with unsaturated ether substituents
US3072585A (en) 1960-01-13 1963-01-08 American Cyanamid Co Vinylbenzyloxy phenylbenzotriazoles
US3133042A (en) 1960-09-09 1964-05-12 Du Pont Polymeric compositions and process
BE630548A (en) 1961-06-16
US3162676A (en) 1962-06-18 1964-12-22 Nat Starch Chem Corp Ethylenically unsaturated derivatives of 2, 4-dihydroxybenzophenone
US3328491A (en) 1964-05-01 1967-06-27 Nat Starch Chem Corp Uv light absorbing copolymers of acryloxymethyl benzoates and dihydroxybenzophenone derivatives
US3493539A (en) 1968-11-13 1970-02-03 Nat Starch Chem Corp Ethylenically unsaturated derivatives of 2-(2-hydroxyphenyl) benzotriazole and polymers therefrom
USRE33477E (en) 1973-06-20 1990-12-04 Wesley-Jessen, Inc. Ultraviolet absorbing hydrophilic corneal contact lenses
US4390676A (en) 1976-11-15 1983-06-28 Schering Corporation Ultraviolet absorbing lenses
US4321396A (en) 1980-01-17 1982-03-23 Gaf Corporation Copolymerizable, ultraviolet light absorber allyloxy-2-(2H-benzotriazol-2-yl)-4-alkylbenzenes
US4260768A (en) 1980-01-17 1981-04-07 Gaf Corporation Copolymerizable, ultraviolet light absorber 2-(2H-benzotriazol-2-yl)-4-alkylphenol acrylic acid esters
US4310687A (en) 1980-07-10 1982-01-12 Gaf Corporation Copolymerizable ultraviolet light absorber monomers which are acrylate esters of 2-hydroxy, alkoxy, methylol benzophenones
US4508882A (en) 1981-08-24 1985-04-02 Asahi Glass Company Ltd. Benzotriazole compound and homopolymer or copolymers thereof
US4636212A (en) 1982-05-10 1987-01-13 Optical Radiation Corporation Ultraviolet radiation absorbing intraocular lens
US4528311A (en) 1983-07-11 1985-07-09 Iolab Corporation Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxyphenyl-2H-benzotriazoles
EP0133164B1 (en) 1983-07-26 1988-12-14 Ciba-Geigy Ag Compounds which can be copolymerised
US4740070A (en) 1984-06-05 1988-04-26 Ppg Industries, Inc. Optical filter
US5187207A (en) 1984-06-08 1993-02-16 Photoprotective Technologies, Inc. Melanin hydrophilic contact lenses
US5036115A (en) 1984-06-08 1991-07-30 Photoprotective Technologies, Inc. Optical lens system incorporating melanin as an absorbing pigment for protection against electromagnetic radiation
US4783361A (en) 1984-09-10 1988-11-08 Ovonic Synthetic Materials Company, Inc. Coated lenses
DE3439483A1 (en) 1984-10-27 1986-05-07 Röhm GmbH, 6100 Darmstadt RADICALLY POLYMERIZABLE UV ABSORBER, METHOD FOR PRODUCING IT AND ITS POLYMERS
US5135965A (en) 1984-12-18 1992-08-04 T. R. Developments, Ltd. Hydrogel-forming polymers used in intraocular lenses
US5002979A (en) 1985-01-29 1991-03-26 Bausch & Lomb Incorporated Extended-wear lenses
US5084537A (en) 1985-01-29 1992-01-28 Bausch & Lomb, Incorporated UV-absorbing extended-wear Lenses
US4753654A (en) 1985-03-18 1988-06-28 Optical Radiation Corporation Ultraviolet radiation absorbing intraocular lens
SE8503522D0 (en) 1985-07-19 1985-07-19 Pharmacia Ab UV-ABSORBING LENS MATERIAL
US4719248A (en) 1985-08-08 1988-01-12 Bausch & Lomb Incorporated Ultraviolet blocking agents for contact lenses
US4716234A (en) 1986-12-01 1987-12-29 Iolab Corporation Ultraviolet absorbing polymers comprising 2-(2'-hydroxy-5'-acryloyloxyalkoxyphenyl)-2H-benzotriazole
US4868251A (en) * 1986-12-24 1989-09-19 Allergan, Inc. Ultraviolet light absorbing silicone compositions
US4872877A (en) 1987-03-17 1989-10-10 Dennis T. Grendahl Intraocular lens with ultraviolet screening agent
US4853374A (en) 1987-06-09 1989-08-01 M.D.R. Group, Inc. Viscoelastic vitreous substitute with UV blocker
US5099027A (en) 1987-08-12 1992-03-24 Ppg Industries, Inc. 2(2-hydroxyphenyl)2H-benzotriazole compounds and homopolymers or copolymers thereof
US5194544A (en) 1987-10-15 1993-03-16 University Of Florida UV absorbing vinyl monomers and polymers and ocular implants prepared therefrom
US5374663A (en) 1988-03-03 1994-12-20 Hoya Corporation Process for producing cyanopsia-correctable intraocular lens
US4845180A (en) 1988-03-21 1989-07-04 Allergan, Inc. Ultraviolet light absorbing compounds, compositions and methods for making same
JPH0761357B2 (en) 1988-03-28 1995-07-05 ホーヤ株式会社 Intraocular lens
US5133745A (en) 1988-05-26 1992-07-28 Alcon Laboratories, Inc. Ultraviolet absorbing hydrogels
US5106930A (en) 1988-09-28 1992-04-21 Ioptex Research Inc. Contact lenses
DE3837884A1 (en) 1988-11-08 1990-05-10 Mutzhas Maximilian F LIGHT FILTER FOR IMPROVING VISION
US5298033A (en) 1989-03-14 1994-03-29 Ciba-Geigy Corporation Ultraviolet absorbing lenses and methods of manufacturing thereof
US4929250A (en) 1989-03-14 1990-05-29 Ciba-Geigy Corporation Ultraviolet absorbing lenses and method of making the same
US4963160A (en) 1989-03-14 1990-10-16 Ciba-Geigy Corporation Reactive uv absorbing compositions and method of preparing lenses therefrom
US5194456A (en) 1989-12-04 1993-03-16 Ioptex Research, Inc. Uv absorbers and pmma material containing such absorbers
US5252628A (en) 1989-12-07 1993-10-12 Lions Eye Institute Of Western Australia, Inc. Method of making photoprotective hydrophilic polymers and ocular devices thereof
JP2613486B2 (en) 1990-03-30 1997-05-28 旭光学工業株式会社 Laminated spectacle lens and method of manufacturing the same
US5290892A (en) 1990-11-07 1994-03-01 Nestle S.A. Flexible intraocular lenses made from high refractive index polymers
JP2685980B2 (en) 1990-11-26 1997-12-08 株式会社メニコン UV absorbing intraocular lens
US5164462A (en) 1991-04-25 1992-11-17 Allergan, Inc. Ultraviolet light absorbing compounds and silicone compositions
JP3195662B2 (en) 1992-08-24 2001-08-06 株式会社メニコン Ophthalmic lens materials
ES2109697T3 (en) 1993-04-22 1998-01-16 Jessen Wesley Corp BENZOTRIAZOLES THAT ABSORB UV RADIATION THAT HAVE A STYRENE GROUP.
US5480927A (en) 1994-05-20 1996-01-02 Ciba Geigy Corporation Method of increasing the concentration of radiation-absorbing agents in optical and ophthalmic lenses
JP3444660B2 (en) 1994-07-15 2003-09-08 Hoya株式会社 Hard contact lens materials and hard contact lenses
US5910537A (en) * 1994-07-22 1999-06-08 Staar Surgical Company Inc. Biocompatible, optically transparent, ultraviolet light absorbing, polymeric material based upon collagen and method of making
EP0786675B1 (en) * 1996-01-26 2002-11-06 Teijin Chemicals, Ltd. Spectacle lens

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030234459A1 (en) * 2000-05-19 2003-12-25 Nandu Mahendra P. Method for the manufacture of molded polymeric devices using variable frequency microwaves
WO2004091883A1 (en) * 2003-03-31 2004-10-28 Bausch & Lomb Incorporated Method for the manufacture of molded polymeric articles using variable frequency microwaves
US9119710B2 (en) * 2005-09-08 2015-09-01 Calhoun Vision, Inc. Adjustable optical elements with enhanced ultraviolet protection
US20070055369A1 (en) * 2005-09-08 2007-03-08 Calhoun Vision, Inc Novel adjustable optical elements with enhanced ultraviolet protection
WO2007030799A3 (en) * 2005-09-08 2007-12-21 Calhoun Vision Inc Novel adjustable optical elements with enhanced ultraviolet protection
US10470874B2 (en) * 2005-09-08 2019-11-12 Rxsight, Inc. Adjustable optical elements with enhanced ultraviolet protection
EP3123980A1 (en) * 2005-09-08 2017-02-01 Calhoun Vision, Inc. Adjustable optical elements with enhanced ultraviolet protection
US20170020658A1 (en) * 2005-09-08 2017-01-26 Calhoun Vision, Inc, Novel adjustable optical elements with enhanced ultraviolet protection
WO2012015639A1 (en) * 2010-07-30 2012-02-02 Novartis Ag Method for making uv-absorbing ophthalmic lenses
US9052439B2 (en) 2010-07-30 2015-06-09 Novartis Ag Method for making UV-absorbing ophthalmic lenses
RU2569365C2 (en) * 2010-07-30 2015-11-27 Новартис Аг Method of making uv-absorbing ophthalmic lenses
AU2011283028B2 (en) * 2010-07-30 2013-08-29 Alcon Inc. Method for making UV-absorbing ophthalmic lenses
CN103038698A (en) * 2010-07-30 2013-04-10 诺瓦提斯公司 Method for making uv-absorbing ophthalmic lenses
US9005700B2 (en) 2011-10-12 2015-04-14 Novartis Ag Method for making UV-absorbing ophthalmic lenses
US10338408B2 (en) 2012-12-17 2019-07-02 Novartis Ag Method for making improved UV-absorbing ophthalmic lenses
US10647874B2 (en) 2016-01-21 2020-05-12 Rohm And Haas Company Polymer dispersion for durable coating, and the coating comprising the same

Also Published As

Publication number Publication date
KR20010084879A (en) 2001-09-06
EP1096905B1 (en) 2006-02-08
MXPA01000783A (en) 2003-03-12
BR9912324A (en) 2001-04-24
CA2338245A1 (en) 2000-02-03
CA2338245C (en) 2005-04-12
CN1317955A (en) 2001-10-17
EP1096905A4 (en) 2001-09-26
AU757384B2 (en) 2003-02-20
DE69929798T2 (en) 2006-10-12
JP2002521705A (en) 2002-07-16
EP1096905A1 (en) 2001-05-09
DE69929798D1 (en) 2006-04-20
WO2000004848A1 (en) 2000-02-03
ATE317250T1 (en) 2006-02-15
US6244707B1 (en) 2001-06-12
AU5211799A (en) 2000-02-14

Similar Documents

Publication Publication Date Title
US6244707B1 (en) UV blocking lenses and material containing benzotriazoles and benzophenones
CA2160677C (en) Uv-absorbing benzotriazoles having a styrene group
US6326448B1 (en) Soft intraocular lens material
US4093361A (en) Composite prosthetic polymeric devices
US5708049A (en) Colored contact lens and method for producing the same
JP2604799B2 (en) Intraocular lens material
WO2001030866A1 (en) Sterile photochromic hydrophilic contact lenses
WO2007050394A2 (en) Polymeric radiation-absorbing materials and ophthalmic devices comprising same
EP1003795B1 (en) Ophthalmic lens polymers
EP0600269B1 (en) Soft ocular lens material
KR19990077661A (en) Ocular lens material and process for producing the same
JP2794308B2 (en) Lens material for aphakic eyes
JPH02188717A (en) Soft lens material for eye
KR102279488B1 (en) Blue light blocking contact lens using Tatrazine pigment and its manufacturing method
JP2022190923A (en) Blue light-absorbing hydrogel
JP3040259B2 (en) Ophthalmic lens materials
WO2023030716A1 (en) Ophthalmic devices
JP3329899B2 (en) Water-containing ophthalmic lens material
JPH02198415A (en) Ocular lens material
JPH02195962A (en) Intra-eye lens material
JPH03122612A (en) Ocular lens material
JPS61144602A (en) Contact optical object

Legal Events

Date Code Title Description
AS Assignment

Owner name: NOVARTIS AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WESLEY JESSEN CORPORATION;REEL/FRAME:013852/0622

Effective date: 20021218

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION